An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis

NCT00751881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1169

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Placebo
DRUG: Teriflunomide

Sponsor

Sanofi